ethyl (2Z)-2-chloro-2-[2-(2,5-dichlorophenyl)hydrazin-1-ylidene]acetate, 95.0%, 1g

2,3-Dimethyl-3H-imidazo[4,5-c]pyridine, 95%, 100mg

Diethyl 2-propylimidazole-4,5-dicarboxylate, 95.0%, 100g

5-Amino-2-fluorobenzylamine, 98.0%, 25g

CYCLOPROPANECARBOXYLIC ACID, 1-(4-METHYLPHENYL)-, METHYL ESTER, 95.0%, 250mg

(2E)-1-(4-ethoxyphenyl)-3-(3-fluorophenyl)prop-2-en-1-one, 95.0%, 10g

3-BROMO-4-METHOXY-1-METHYLPYRIDIN-2(1H)-ONE, 95.0%, 250mg

GC capillary column ROTI®Cap-1 MS, 12 m, 0.20 mm, 0.35 µm, 1 Piece(s)

2-(4,4-Dimethyl-1-cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 100mg

METHYL BETA-D-GLUCOPYRANOSIDE, 95%, 5g

2,6-Diphenylpyridine>99.0%(GC)5g

5-Bromo-N1-isopropylbenzene-1,2-diamine, 95+%, 5g

2-Amino-4-(trifluoromethyl)benzonitrile, 95.0%, 5g